Viracta Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
16 May 2024	Form 3: Faerm Michael E., Chief Financial Officer No securities owned
22 Mar 2024	Form 3: Burcar Melody, Senior VP, Finance
16 Aug 2023	Form 3: Cohen Darrel P., Chief Medical Officer No securities owned
19 Sep 2022	Form 3: Rothera Mark, Director No securities owned
11 Aug 2022	Form 3: Chung Jane, Director No securities owned
17 Aug 2021	Form 3: Borellini Flavia, Director No securities owned
17 Aug 2021	Form 3: Barlow Jane F, Director No securities owned
04 Mar 2021	Form 3: Simon Barry J., Director
04 Mar 2021	Form 3: Rubino Stephen, Director No securities owned
25 Feb 2021	Form 3: aMoon 2 Fund Limited Partnership, 10% owner and 1 other Holds 5,359,372 shares of Common Stock
25 Feb 2021	Form 3: Roshwalb Gur, Director Holds 2,032,865 shares of Common Stock
24 Feb 2021	Form 3: Chevallard Daniel R., Chief Executive Officer Holds 44,760 shares of Common Stock
24 Feb 2021	Form 3: Darcy Thomas E, Director No securities owned
24 Feb 2021	Form 3: Huang Michael, Director No securities owned
24 Feb 2021	Form 3: Murphy Samuel Lafayette, Director No securities owned
24 Feb 2021	Form 3: Pomerantz Roger, Director
24 Feb 2021	Form 3: Rojkjaer Lisa, Chief Medical Officer
24 Feb 2021	Form 3: Royston Ivor, Director Holds 540,599 shares of Common Stock
07 Jan 2021	Form 3: Hyare Parvinder S, See Remarks Holds 960 shares of Common Stock
05 May 2020	Form 3: Gullotta Tina, VP, Finance Holds 14,500 shares of Common Stock

Comments